These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15592324)

  • 21. Pharmacology of irinotecan.
    Kuhn JG
    Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):39-42. PubMed ID: 9726089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-6 alters the cellular responsiveness to clopidogrel, irinotecan, and oseltamivir by suppressing the expression of carboxylesterases HCE1 and HCE2.
    Yang J; Shi D; Yang D; Song X; Yan B
    Mol Pharmacol; 2007 Sep; 72(3):686-94. PubMed ID: 17537833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzyme-prodrug systems: carboxylesterase/CPT-11.
    Danks MK; Potter PM
    Methods Mol Med; 2004; 90():247-62. PubMed ID: 14657567
    [No Abstract]   [Full Text] [Related]  

  • 24. A virus-directed enzyme prodrug therapy approach to purging neuroblastoma cells from hematopoietic cells using adenovirus encoding rabbit carboxylesterase and CPT-11.
    Meck MM; Wierdl M; Wagner LM; Burger RA; Guichard SM; Krull EJ; Harris LC; Potter PM; Danks MK
    Cancer Res; 2001 Jul; 61(13):5083-9. PubMed ID: 11431345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human carboxylesterase 2 is commonly expressed in tumor tissue and is correlated with activation of irinotecan.
    Xu G; Zhang W; Ma MK; McLeod HL
    Clin Cancer Res; 2002 Aug; 8(8):2605-11. PubMed ID: 12171891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo human carboxylesterase cDNA gene transfer to activate the prodrug CPT-11 for local treatment of solid tumors.
    Kojima A; Hackett NR; Ohwada A; Crystal RG
    J Clin Invest; 1998 Apr; 101(8):1789-96. PubMed ID: 9541511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous administration of irinotecan elevates the blood beta-glucuronidase activity in rats.
    Kaneda N; Kurita A; Hosokawa Y; Yokokura T; Awazu S
    Cancer Res; 1997 Dec; 57(23):5305-8. PubMed ID: 9393754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular localization domains of a rabbit and a human carboxylesterase: influence on irinotecan (CPT-11) metabolism by the rabbit enzyme.
    Potter PM; Wolverton JS; Morton CL; Wierdl M; Danks MK
    Cancer Res; 1998 Aug; 58(16):3627-32. PubMed ID: 9721871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of rat serum carboxylesterase in the activation of paclitaxel and camptothecin prodrugs.
    Senter PD; Marquardt H; Thomas BA; Hammock BD; Frank IS; Svensson HP
    Cancer Res; 1996 Apr; 56(7):1471-4. PubMed ID: 8603386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and characterization of a human carboxylesterase 2 splice variant.
    Schiel MA; Green SL; Davis WI; Sanghani PC; Bosron WF; Sanghani SP
    J Pharmacol Exp Ther; 2007 Oct; 323(1):94-101. PubMed ID: 17636009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioactivation of the anticancer agent CPT-11 to SN-38 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactions.
    Slatter JG; Su P; Sams JP; Schaaf LJ; Wienkers LC
    Drug Metab Dispos; 1997 Oct; 25(10):1157-64. PubMed ID: 9321519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The in vitro metabolism of irinotecan (CPT-11) by carboxylesterase and beta-glucuronidase in human colorectal tumours.
    Tobin P; Clarke S; Seale JP; Lee S; Solomon M; Aulds S; Crawford M; Gallagher J; Eyers T; Rivory L
    Br J Clin Pharmacol; 2006 Jul; 62(1):122-9. PubMed ID: 16842384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural constraints affect the metabolism of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) by carboxylesterases.
    Wadkins RM; Morton CL; Weeks JK; Oliver L; Wierdl M; Danks MK; Potter PM
    Mol Pharmacol; 2001 Aug; 60(2):355-62. PubMed ID: 11455023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human plasma carboxylesterase and butyrylcholinesterase enzyme activity: correlations with SN-38 pharmacokinetics during a prolonged infusion of irinotecan.
    Guemei AA; Cottrell J; Band R; Hehman H; Prudhomme M; Pavlov MV; Grem JL; Ismail AS; Bowen D; Taylor RE; Takimoto CH
    Cancer Chemother Pharmacol; 2001 Apr; 47(4):283-90. PubMed ID: 11345644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitization of human tumor cells to CPT-11 via adenoviral-mediated delivery of a rabbit liver carboxylesterase.
    Wierdl M; Morton CL; Weeks JK; Danks MK; Harris LC; Potter PM
    Cancer Res; 2001 Jul; 61(13):5078-82. PubMed ID: 11431344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms.
    Nozawa T; Minami H; Sugiura S; Tsuji A; Tamai I
    Drug Metab Dispos; 2005 Mar; 33(3):434-9. PubMed ID: 15608127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells.
    Wu MH; Yan B; Humerickhouse R; Dolan ME
    Clin Cancer Res; 2002 Aug; 8(8):2696-700. PubMed ID: 12171903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural insights into CPT-11 activation by mammalian carboxylesterases.
    Bencharit S; Morton CL; Howard-Williams EL; Danks MK; Potter PM; Redinbo MR
    Nat Struct Biol; 2002 May; 9(5):337-42. PubMed ID: 11967565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Organ-specific carboxylesterase profiling identifies the small intestine and kidney as major contributors of activation of the anticancer prodrug CPT-11.
    Hatfield MJ; Tsurkan L; Garrett M; Shaver TM; Hyatt JL; Edwards CC; Hicks LD; Potter PM
    Biochem Pharmacol; 2011 Jan; 81(1):24-31. PubMed ID: 20833148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age- and sex-related expression and activity of carboxylesterase 1 and 2 in mouse and human liver.
    Zhu HJ; Appel DI; Jiang Y; Markowitz JS
    Drug Metab Dispos; 2009 Sep; 37(9):1819-25. PubMed ID: 19487248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.